Kohei Omatsu

Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma

Osamu Gotoh, Yuko Sugiyama, Yutaka Takazawa et al. · Nature Communications · 2019 · 146 citations · Full text

Somatic Variant, Tumor Heterogeneity, Medicine +14

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma

Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross et al. · Annals of Oncology · 2016 · 102 citations · Full text

Tumoral Pathology, Sarcoma Components, Medicine +10

Adjuvant Chemotherapy for Stage I Clear Cell Carcinoma of the Ovary

Toshio Takada, Haruko Iwase, Chiaki Iitsuka et al. · International Journal of Gynecological Cancer · 2012 · 45 citations

Comparison of survival between upfront primary debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomized trial: JCOG0602.

Takashi Onda, Toyomi Satoh, Toshiaki Saito et al. · Journal of Clinical Oncology · 2018 · 45 citations

Surgical Oncology, Cancer Management, Gynecology +20

Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer—Irinotecan and platinum chemotherapy

Maki Matsumura, Nobuhiro Takeshima, Tsuyoshi Ota et al. · Gynecologic Oncology · 2010 · 42 citations

Cervical Cancer Management, Surgical Oncology, Cervical Cancer +13